RegenETP Statistics
Total Valuation
RegenETP has a market cap or net worth of 1.12 million.
| Market Cap | 1.12M |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
RegenETP has 7.19 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 7.19M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +1.14% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.00% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 15.37 |
| PB Ratio | 0.09 |
| P/TBV Ratio | 0.09 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.11, with a Debt / Equity ratio of 0.24.
| Current Ratio | 4.11 |
| Quick Ratio | 3.15 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.14 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -54.97% and return on invested capital (ROIC) is -76.30%.
| Return on Equity (ROE) | -54.97% |
| Return on Assets (ROA) | -56.67% |
| Return on Invested Capital (ROIC) | -76.30% |
| Return on Capital Employed (ROCE) | -137.33% |
| Revenue Per Employee | 1,698 |
| Profits Per Employee | -193,140 |
| Employee Count | 43 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +688.18% in the last 52 weeks. The beta is 2.91, so RegenETP's price volatility has been higher than the market average.
| Beta (5Y) | 2.91 |
| 52-Week Price Change | +688.18% |
| 50-Day Moving Average | 0.14 |
| 200-Day Moving Average | 0.12 |
| Relative Strength Index (RSI) | 51.79 |
| Average Volume (20 Days) | 5,536 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.51 |
Income Statement
In the last 12 months, RegenETP had revenue of 73,000 and -8.31 million in losses. Loss per share was -1.09.
| Revenue | 73,000 |
| Gross Profit | -52,000 |
| Operating Income | -21.80M |
| Pretax Income | -8.31M |
| Net Income | -8.31M |
| EBITDA | -20.60M |
| EBIT | -21.80M |
| Loss Per Share | -1.09 |
Balance Sheet
The company has 6.39 million in cash and 2.95 million in debt, giving a net cash position of 3.44 million or 0.48 per share.
| Cash & Cash Equivalents | 6.39M |
| Total Debt | 2.95M |
| Net Cash | 3.44M |
| Net Cash Per Share | 0.48 |
| Equity (Book Value) | 12.42M |
| Book Value Per Share | 1.74 |
| Working Capital | 6.76M |
Cash Flow
In the last 12 months, operating cash flow was -21.64 million and capital expenditures -6,000, giving a free cash flow of -21.64 million.
| Operating Cash Flow | -21.64M |
| Capital Expenditures | -6,000 |
| Free Cash Flow | -21.64M |
| FCF Per Share | -3.01 |
Margins
| Gross Margin | -71.23% |
| Operating Margin | -29,868.49% |
| Pretax Margin | -11,376.71% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
RegenETP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -139.08% |
| Shareholder Yield | -139.08% |
| Earnings Yield | -740.09% |
| FCF Yield | -1,928.59% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 17, 2022. It was a reverse split with a ratio of 0.04.
| Last Split Date | May 17, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.04 |
Scores
RegenETP has an Altman Z-Score of -43.11. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -43.11 |
| Piotroski F-Score | n/a |